HomeBiosimilar Antibodies

Biosimilar Antibodies

Cat.No. Product Name Information Isotype
A3088 Mitazalimab (Anti-TNFRSF5 / CD40) Mitazalimab (Anti-TNFRSF5 / CD40) a human agonist IgG1 antibody targeting CD40. It enhances the anti-tumor efficacy of a model cancer vaccine. MW :143.44 KD. Human IgG1
A2833 Donanemab (Anti-Amyloid Beta) Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody directed at an N‐terminal pyroglutamate amyloid beta (Aβ) epitope. Donanemab has the potential for early Alzheimer's disease research. MW : 145.36 KD. Human IgG1
A3089 Ravagalimab (Anti-TNFRSF5 / CD40) Ravagalimab (Anti-TNFRSF5 / CD40) is a monoclonal antibody targeting CD40. It can be used for research of Crohn's disease. MW :146.04 KD. Human IgG1
A2834 Grisnilimab (Anti-CD7) Grisnilimab (Anti-CD7) is an IgG2a monoclonal antibody against CD7. Grisnilimab regulates the transcription of multiple target genes and may participate in the post-transcriptional processing of RNA. MW : 144.72 KD. Human IgG2SA
A2835 Dostarlimab (Anti-PDCD1 / PD-1 / CD279) Dostarlimab (Anti-PDCD1 / PD-1 / CD279) is a humanized monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed cell death 1 ((PD-1  programmed death-1), with potential immune checkpoint inhibitory and antineoplastic activities. MW : 144.18 KD. Human IgG4SP
A3091 Anti-GAD65 Anti-GAD65 is an autoantibody targeting glutamic acid decarboxylase (GAD65). It is used in treatment of Stiff person syndrome (SPS). MW :146.38 KD. Human IgG1
A2836 Iladatuzumab (Anti-CD79b) Iladatuzumab (Anti-CD79b) is a humanized IgG1 monoclonal antibody against CD79 B, a cell-surface antigen expressed on mature B cells. MW : 145.18 KD. Human IgG1
A3092 Anti-MICB Anti-MICB is an antibody that specifically target human major histocompatibility complex class I chain-related A and B (MICA/B). It can be used in treating a cancer. MW :143.66 KD. Human IgG2SA
A2837 Anti-CD83 Anti-CD83 is a humanized monoclonal antibody against CD83 with the potential to treat auto-immune diseases. MW: 144.8 KD. Human IgG2SA
A3093 Tabalumab (Anti-TNFSF13B / BAFF / CD257) Tabalumab (Anti-TNFSF13B / BAFF / CD257) is a humanised monoclonal antibody BAFF (B-cell activating factor). It can be used in studies of autoimmune diseases such as rheumatoid arthritis, renal failure and systemic lupus erythematosus. MW :146.2 KD. Human IgG4SP
A2838 Anti-CD9 Anti-CD9 is a humanized monoclonal antibody against CD9 with potential anti-tumor activity. MW: 145.98 KD. Human IgG1
A3094 Anti-TNFSF14 / LIGHT / CD258 (SAR252067) Anti-TNFSF14 / LIGHT / CD258 (SAR252067) is a fully human monoclonal antibody targeting LIGHT. It can be used in treatment of treatment of ulcerative colitis and crohn's disease. MW :141.8 KD. Human IgG1
A2839 Anti-CDH1 / E-cadherin / CD324 Anti-CDH1 / E-cadherin / CD324 is an IgG1 monoclonal antibody against E-cadherin, an epithelial adhesion molecule. MW: 146.6 KD. Human IgG1
A3095 Anti-TNFSF2 / TNFa (CDP571) Anti-TNFSF2 / TNFa (CDP571) is an antibody targeting tumor necrosis factor (TNF).It can be used in the treatment of rheumatoid arthritis (RA). MW :146.9 KD. Human IgG4SP
A2841 Cergutuzumab (Anti-CEACAM5 / CEA / CD66e) Cergutuzumab (Anti-CEACAM5 / CEA / CD66e) is a humanized monoclonal antibody which targets Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) with immunostimulating and antineoplastic activities. MW : 146.48 KD. Human IgG1
A3097 Anti-TNFSF2 / TNFa (CMAB008) Anti-TNFSF2 / TNFa (CMAB008) is an antibody targeting tumor necrosis factor (TNF).It can be used in the treatment of rheumatoid arthritis (RA). MW :147.16 KD. Human IgG1
A2842 Ebdarokimab (Anti-IL-12b) Ebdarokimab (Anti-IL-12b) is a fully human monoclonal antibody (mAb) targeting Interleukin-12/Interleukin-23 (IL-12/IL-23) pathway. Ebdarokimab has the potential to treat moderate to severe plaque psoriasis. MW : 145.6 KD. Human IgG1
A3098 Anti-TNFSF2 / TNFa (ESBA 105) Anti-TNFSF2 / TNFa (ESBA 105) is an antibody targeting tumor necrosis factor (TNF).It has an efficient intraocular penetration to anterior and posterior region of eye. MW :145.14 KD. Human IgG1
A2843 Ebronucimab (Anti-PCSK9) Ebronucimab (Anti-PCSK9) is a fully human immunoglobulin G1 (IgG1) monoclonal antibody against proprotein convertase subtilisin/kexin type 9 (PCSK9) used to treat hyperlipidemia. MW : 144.76 KD. Human IgG1
A3099 Anti-TNFSF2 / TNFa (hMAK195) Anti-TNFSF2 / TNFa (hMAK195) is an antibody targeting tumor necrosis factor (TNF).It can be used in the treatment of rheumatoid arthritis (RA). MW :145.06 KD. Human IgG1